US President Donald Trump’s move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 is unlikely to have an immediate impact
In a new study, investigators compared the effects of repeated intravenous (IV) ketamine and intranasal (IN) esketamine in patients with treatment-resistant depression and found both
Novartis will present new data from 34 abstracts across its oncology portfolio at the European Society for Medical Oncology (ESMO) Congress 2025 in Berlin (October
Novartis has announced plans to acquire Tourmaline Bio for $48 per share, valuing the New York-based biotech at $1.4 billion, strengthening its cardiovascular disease portfolio
The healthcare industry in the country is in the midst of a digital revolution, with diagnostics at the core of this transformation. The shift of
In a move highlighting a ‘silent crisis’ threatening their survival, a Joint Forum of Pharmaceutical MSMEs Associations of India has sent a representation to Union
NIHR and the Office for Life Sciences (OLS) are collaborating to support UK researchers to develop the skills to deliver innovative drug and alcohol addiction
According to a study funded by the National Institutes of Health (NIH), older Americans with chronic low back pain who received acupuncture had greater improvement
Indian pharma companies are moving away from merely supplying me-too versions of blockbuster drugs. Instead, these companies are increasingly leveraging the US FDA’s 505(b)(2) regulatory
Russian scientists have developed a new cancer vaccine that is now ready for clinical use, according to the Federal Medical and Biological Agency (FMBA). The
Copyright © 2025 Gubba Cold Storage Ltd, All rights reserved. Designed, Developed by TenJump